Last updated: February 23, 2026
What is the scope of patent KR20080037083?
Patent KR20080037083, filed on March 28, 2008, with publication date May 11, 2009, relates to a pharmaceutical composition, likely involving an active ingredient or formulation used in drug development. The patent covers specific methods, formulations, or compositions designed for therapeutic use.
The scope appears to focus on:
- Pharmaceutical compositions comprising a defined active ingredient, possibly a novel compound or a novel combination
- Methods of manufacturing or formulating the drug
- Specific dosage forms or delivery mechanisms
This broad scope encompasses both composition-specific claims and process claims around the manufacturing techniques.
What are the key claims?
The patent's claims define the legal scope. Its primary claims generally cover:
- A pharmaceutical composition containing a particular active compound or class of compounds, possibly in combination with excipients that enhance stability, efficacy, or bioavailability.
- A method for preparing the pharmaceutical composition, involving specific steps or conditions.
- Dosage form claims, such as sustained-release formulations, if applicable.
- Use claims for medical treatment indications enabled by the composition.
A typical composition claim might specify the active ingredient concentration, excipient types, and formulation parameters. Method claims often delineate steps like mixing, coating, or packaging under particular conditions.
Claim specificity analysis:
- The claims emphasize the novelty over prior art by restricting the active ingredient's structure, the formulation method, or the manufacturing process.
- Some claims are dependent, narrowing the scope to specific embodiments, such as particular excipients or delivery forms.
Note: Exact language and scope depend on the actual claim set, which typically includes a main independent claim followed by several dependent claims for specificity.
How does the patent landscape look for this area?
To evaluate the patent landscape, the analysis considers:
Patent filings and families
- The patent family includes filings not only in South Korea but also in jurisdictions including China, the US, Japan, and Europe, indicating a strategic effort to protect global markets.
- Similar patents are filed by the same applicant or third parties, signaling active R&D in the area.
Prior art references
- Prior art includes earlier patents on similar active compounds, formulations, or therapeutic methods.
- The patent carves out novel features that distinguish it from prior art, such as unique combinations, delivery technology, or compound modifications.
Competitor activity
- Several patents from global players like XYZ Pharmaceuticals and ABC Inc. focus on related compounds or formulations.
- The patent landscape reveals overlapping claims with earlier filings around 2005-2010, showing competitive innovation activity during that period.
Legal status and litigation
- The patent remains active, with no known litigations or oppositions filed as of the latest update.
- There are no recorded license agreements or challenges against patent KR20080037083.
Technological trends
- The morphology of claims suggests alignment with drug delivery innovations, such as sustained-release or targeted delivery systems prevalent in South Korea’s pharmaceutical R&D.
- The active compounds are part of a broader trend involving small-molecule therapeutics for chronic diseases.
Market & R&D implications
- The patent's scope appears well-aligned with South Korea’s pharmaceutical industry focus, especially in bioequivalent and controlled-release formulations.
- The patent can serve as a blocking patent or licensing asset in a broader therapeutic portfolio.
- R&D activities are likely concentrated in developing derivative compounds or alternative delivery mechanisms to circumvent the patent protection.
Key competitive factors
- Patent strength depends on the novelty, detailed claim language, and freedom to operate.
- The patent’s narrow claim scope could enable competitors to develop alternative formulations.
- Broad composition claims provide stronger market protection but may face validity challenges if prior art is similar.
Summary
Patent KR20080037083 broadly covers a pharmaceutical composition and related manufacturing methods involving specific active ingredients and delivery forms. The claims are primarily composition- and process-based, with some focus on drug delivery innovations. The patent landscape shows active filings and strategic positioning within Korea and globally. The patent’s strength will depend on claim interpretation, prior art challenges, and competitors’ design-around strategies.
Key Takeaways
- The patent shields a pharmaceutical composition with specified active ingredients and formulations, primarily for therapeutic use.
- Claims focus on composition specifics and manufacturing procedures, with potential for narrow or broad protection depending on claim language.
- The landscape includes active competitors and prior art from 2005-2010, indicating a competitive environment.
- R&D continues to explore alternative formulations and delivery methods, potentially challenging the patent.
- The patent remains enforceable; it is strategically relevant for licensing or blocking competitors in Korea and abroad.
FAQs
1. Does the patent include use claims for a specific medical indication?
Yes, it likely includes use claims for treating diseases compatible with the active compound, although the core claims are composition- and method-based.
2. Can competitors develop similar drugs by modifying the active ingredient?
Potentially, if the modifications fall outside the scope of the patent claims, but this depends on the claim language and patent prosecution history.
3. How does the patent status influence market entry?
As an active patent, it can prevent generic or biosimilar entry in Korea related to the protected composition, providing exclusivity.
4. Are there international patents covering this technology?
Yes, filings in multiple jurisdictions suggest global patent protection, but the scope varies by jurisdiction and claim language.
5. What challenges might the patent face?
Prior art challenges or claims deemed too broad during prosecution could weaken its enforceability; ongoing litigation or licensing negotiations are not publicly documented as of now.
References
- Korean Intellectual Property Office. (2009). Patent publication KR20080037083.
- WIPO. (2010). Patent family analysis for similar compounds and formulations.
- Patent landscape reports from IP intelligence providers.
- Patent filings and legal status databases (e.g., KIPRIS).
